TEVA ▼ -0.5% - Teva Pharmaceutical Industries Limited $TEVA - New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients Teva Pharmaceutical Industries fell 0.5% today after releasing results from a study on healthcare provider preferences for tardive dyskinesia treatments in older patients. The research identifies which clinical attributes physicians prioritize when choosing therapies in this population, potentially informing Teva's product positioning and development strategy in the movement disorder space. 18-SEP-2026 04:32 PM ET